Michael Mühlegger

Senior Director Marketing & Inside Sales

m.muehlegger@susupport.com

Michael Mühlegger is the Head of Marketing and Inside Sales at Single Use Support. He has 10+ years experience in the fields of marketing, inside sales, communications, content management, and creative production. With a keen understanding of market dynamics and customer behavior, Michael has successfully implemented innovative marketing strategies to drive business growth and enhance brand visibility.

He has a strong background in content management, with a focus on life sciences and biopharma trends, and is adept at creating compelling content across multiple platforms to engage audiences and effectively communicate brand messages.

Articles written by Michael Mühlegger

Drug Delivery

Pros & Cons of lipid nanoparticles for mRNA delivery

Lipid nanoparticles are highly valued tools in the field of mRNA delivery, making them essential for various therapeutic and research approaches. In this article, we will take a look at the pros and cons of LNPs in mRNA delivery.

Michael Mühlegger

June 17, 2023

Drug Delivery

Non-viral vectors in gene therapy: LNPs in the spotlight

Non-viral vectors play an increasingly important role in biomedical research and therapy, including gene therapy. In this article, we will discuss the role of non-viral vectors for this specific purpose.

Michael Mühlegger

June 13, 2023

FDA approved antibody-drug conjugates for cancer therapy

Bioconjugates

FDA approved Antibody Drug Conjugates (ADCs)

ADCs offer new, highly promising approaches in the therapy of various cancer types, and the number of approved ADCs is continuously growing. In this article, we will have a look at ADCs currently approved.

Michael Mühlegger

May 7, 2024

Bioconjugates

Bioconjugation simply explained

Bioconjugation is a pharmaceutical technique that is gaining more and more importance, most of all in cancer therapy. In this article, we will provide some basic information on bioconjugation, but also discuss major challenges related to this field.

Michael Mühlegger

April 20, 2023

Bioprocessing

Automated bioprocessing – 7 advantages of automation

Automation is affecting various aspects of our lives, including bioprocessing. In this article, we will explore the advantages that come with this development.

Michael Mühlegger

April 12, 2023

Biopharma

Biopharma supply chain – 7 risks to be aware of

The entire biopharma industry depends on intact supply chain in order to provide patients with the drug products they need. However, there are several factors that can put the integrity of supply chain at risk. In this article, we will discuss seven of them and explore what can be done to circumvent them.

Michael Mühlegger

March 29, 2023

Bioprocessing

Microbial cGMP production: complete guide & manufacturer's overview

Microbial fermentation is a hot topic not only in the biopharma industry. In this article, you will find a brief overview of microbial fermentation manufacturing before we discover different CDMOs offering microbial cGMP production.

Michael Mühlegger

March 9, 2023

Biopharma

Meeting cGMP regulations with innovative single-use technologies

Manufacturers in the pharmaceutical industry are required to comply with cGMP (Current Good Manufacturing Practice). End-to-end solutions based on automated single-use technologies are an auspicious choice for drug substance manufacturers, given their many advantages. Their implementation in the manufacturing process promises efficiency, high product quality, cost reduction, and energy savings.

Michael Mühlegger

March 1, 2023

Biopharma

cGMP - everything you need to know

The current Good Manufacturing Practice (cGMP) regulations - originated and checked by the FDA - apply to companies operating in pharmaceutical, biotech, or med tech industries. They require the latest standards in terms of production, manufacturing, and packaging and thereby ensure pharmaceutical quality meaning quality in manufacturing processes and patient safety as the ultimate goal. The detailed requirements, importance of cGMP, and how companies can best meet the cGMP regulations, are discussed in the following.

Michael Mühlegger

March 1, 2023

Biopharma

Why CDMOs are increasingly using single-use systems

By combining a number of benefits, single-use technologies that are compliant with cGMP and GAMP seem the perfect choice. For manufacturers of drug substances, they provide a more efficient, cost-effective, and scalable solution than stainless-steel tanks by offering.

Michael Mühlegger

February 10, 2023

Biopharma

How to choose a CDMO? 7 Considerations to be made

Choosing the right CDMO or CMO to work with is an important decision. Irrespective of which stage biopharma and pharma companies find themselves in, there are certain things to consider that are valid for any stage throughout your production process.

Michael Mühlegger

February 10, 2023

Biopharma

CDMO in Biopharma: Opportunity or risk?

Both, CDMOs and CMOs, are offering major opportunities in biopharma for startups and emerging companies as well as for established players who are approaching the limits of their manufacturing facilities or are generally looking to outsource parts of or their entire commercial production.

Michael Mühlegger

February 10, 2023

Newsletter subscription

Get the latest delivered directly to your inbox!

Get the latest delivered directly to your inbox! You can unsubscribe at any time, no hard feelings. Privacy policy.